DrugPatentWatch Database Preview
Hisun Pharm Hangzhou Company Profile
What is the competitive landscape for HISUN PHARM HANGZHOU, and what generic and branded alternatives to HISUN PHARM HANGZHOU drugs are available?
HISUN PHARM HANGZHOU has seven approved drugs.
Summary for Hisun Pharm Hangzhou
| US Patents: | 0 |
| Tradenames: | 6 |
| Ingredients: | 6 |
| NDAs: | 7 |
Drugs and US Patents for Hisun Pharm Hangzhou
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hisun Pharm Hangzhou | IRBESARTAN AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; irbesartan | TABLET;ORAL | 207896-001 | Oct 14, 2016 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Hisun Pharm Hangzhou | DONEPEZIL HYDROCHLORIDE | donepezil hydrochloride | TABLET, ORALLY DISINTEGRATING;ORAL | 205269-001 | Jul 27, 2018 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Hisun Pharm Hangzhou | IRBESARTAN | irbesartan | TABLET;ORAL | 206194-003 | Jun 14, 2016 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
